Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Masatoshi Kudo; Guohong Han; Richard S. Finn; Ronnie T.P. Poon; Jean–Frédéric Blanc; Lünan Yan; Jijin Yang; Ligong Lu; Won Young Tak; Xiaoping Yu; Joon-Hyeok Lee; Shi‐Ming Lin; Changping Wu; Tawesak Tanwandee; Guoliang Shao; Ian Walters; Christine Dela Cruz; Valerie Poulart; Jianhua Wang

doi:10.1002/hep.27290

Related publications

Article2013

Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

Josep M. Llovet, Thomas Decaens, Jean‐Luc Raoul, Éveline Boucher, Masatoshi Kudo, Charissa Chang, Yoon‐Koo Kang, Éric Assenat, Ho-Yeong Lim, Valérie Boige, Philippe Mathurin, Lætitia Fartoux, Deng‐Yn Lin, Jordi Bruix, Ronnie T.P. Poon, Morris Sherman, Jean–Frédéric Blanc, Richard S. Finn, Won Young Tak, Yee Chao, Rana Ezzeddine, David Liu, Ian Walters, Joong‐Won Park

Journal of Clinical Oncology

Article2018

Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial.

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Takuji Torimura, Nobukazu Tanabe, Hiroshi Aikata, Namiki Izumi, Takahiro Yamasaki, Shunsuke Nojiri, Keisuke Hino, Hidetaka Tsumura, Teiji Kuzuya, Norio Isoda, Kohichiroh Yasui, Kenichi Yoshimura, Takuji Okusaka, Junji Furuse, Norihiro Kokudo, Kiwamu Okita, Yasuaki Arai

Article2015

Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma

Tadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, Tomohiro Minami, Hirokazu Chishina, Masashi Kono, Masahiro Takita, Satoshi Kitai, Tatsuo Inoue, Norihisa Yada, Satoru Hagiwara, Hiroshi Ida, Yasunori Minami, Toshiharu Sakurai, Naoshi Nishida, Masayuki Kitano, Masatoshi Kudo

Article2025

Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial

Kang Wang, Jinkai Feng, Hongming Yu, Yuqiang Cheng, Yan‐Jun Xiang, Zonghan Liu, Yingyi Qin, Enyu Liu, Yunfeng Shan, Fan Chen, Jian Zhai, Dandan He, Hongkun Zhou, Yufu Tang, Shi Jie, Wei‐Xing Guo, Mao-Lin Yan, Li Yu, Masatoshi Kudo, Shuqun Cheng

Article2019

Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Masatoshi Kudo